# FDA Inspection 1079946 - Novo Nordisk Pharmaceutical Industries LP - December 20, 2018

Source: https://www.keypedia.com/records/fda_inspections/novo-nordisk-pharmaceutical-industries-lp/1b88bc64-8477-45dc-9b32-54848fa53e48
Source feed: FDA_Inspections

> FDA Inspection 1079946 for Novo Nordisk Pharmaceutical Industries LP on December 20, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1079946
- Company Name: Novo Nordisk Pharmaceutical Industries LP
- Inspection Date: 2018-12-20
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1274952 - 2025-07-30](https://www.keypedia.com/records/fda_inspections/novo-nordisk-pharmaceutical-industries-lp/e1141bb3-b2b2-413f-9358-f7ff198a62e2)
- [FDA Inspection 1274952 - 2025-07-30](https://www.keypedia.com/records/fda_inspections/novo-nordisk-pharmaceutical-industries-lp/8212459f-f02a-495f-b1ee-749ffeee4670)
- [FDA Inspection 1233201 - 2023-12-20](https://www.keypedia.com/records/fda_inspections/novo-nordisk-pharmaceutical-industries-lp/7706c981-9d5b-4539-85a5-19cccb49a6f1)
- [FDA Inspection 1010958 - 2016-12-01](https://www.keypedia.com/records/fda_inspections/novo-nordisk-pharmaceutical-industries-lp/8408a3a0-1a23-4173-b02d-39aa076457fd)

Company: https://www.keypedia.com/companies/novo-nordisk-pharmaceutical-industries-lp/6bd6ea0d-568a-4f97-ba33-f6bbab29a175

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c